| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59.4M | +9.3% | +25.3% |
| R&D Expense | $1.8M | -30.4% | -24.1% |
| SG&A Expense | $5.1M | -11.2% | -1.3% |
| Operating Income | $2.2M | +222.8% | +2120.2% |
| Pre-tax Income | $3.3M | +804.5% | +82.0% |
| Income Tax | $25K | -67.1% | +133.8% |
| Net Income | $3.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.5M | -27.3% | -66.8% |
| Accounts Receivable | $14.9M | -3.2% | +55.5% |
| Current Assets | $114.5M | -5.1% | -13.0% |
| Total Assets | $129.1M | -2.8% | -6.6% |
| Current Liabilities | $19.4M | +4.5% | +1.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.2M | — | — |
| Investing Cash Flow | -$17.7M | — | — |
| Financing Cash Flow | -$18.5M | — | — |
| +700.9% |
| +73.5% |
| EPS (Basic) | $0.02 | — | +100.0% |
| EPS (Diluted) | $0.02 | — | +100.0% |
| $20.0M |
| +0.6% |
| -3.3% |
| Stockholders' Equity | $109.1M | -3.4% | -7.2% |